Cereno Scientific Feed

2026-02-02 14:00:00 Cereno Scientific presenterar program och talare för kapitalmarknadsdagen den 5 februari

2026-02-02 14:00:00 Cereno Scientific Announces Program and Speakers for the Capital Markets Day on February 5, 2026

2026-01-28 13:02:03 Cereno Scientific presenterar CS014-data och deltar i paneldiskussion vid den vetenskapliga konferensen PVRI 2026 i Dublin 6,39 SEK | -1,84% | 3,62 MSEK

2026-01-28 13:02:03 Cereno Scientific to Present CS014 Data and Participate in Panel at Scientific Conference PVRI 2026 Dublin 6,39 SEK | -1,84% | 3,62 MSEK

2026-01-16 07:45:00 Cereno Scientific: Invitation to Capital Markets Day 2026 6,89 SEK | +0,15% | 4,49 MSEK

2026-01-16 07:45:00 Cereno Scientific: Inbjudan till kapitalmarknadsdag den 5 februari 2026 6,89 SEK | +0,15% | 4,49 MSEK

2026-01-14 13:15:00 Cereno Scientific delar första vetenskapliga publikationen om HDAC-hämmaren CS014: Antitrombotisk effekt utan blödningsrisk stödjer bred potential vid kardiopulmonella sjukdomar 6,95 SEK | -2,04% | 3,57 MSEK

2026-01-14 13:15:00 Cereno Scientific Announces First Peer-Reviewed Publication on HDAC Inhibitor CS014: Antithrombotic Efficacy Without Bleeding Risk Supports Broad Potential in Cardiopulmonary Diseases 6,95 SEK | -2,04% | 3,57 MSEK

2026-01-08 10:45:00 Cereno Scientific erhåller cirka 5 miljoner kronor genom utnyttjande av 728 957 teckningsoptioner av Arena Investors, LP 6,96 SEK | +0,87% | 4,06 MSEK

2026-01-08 10:45:00 Cereno Scientific Receives approximately SEK 5 million Through Exercise of 728,957 Warrants by Arena Investors, LP 6,96 SEK | +0,87% | 4,06 MSEK

2025-12-18 14:50:00 Cereno Scientific’s Board of Directors and Management Enter Lock-up Agreements 7,29 SEK | +5,04% | 5,94 MSEK

2025-12-18 14:50:00 Cereno Scientifics styrelse och ledning ingår lock-up avtal 7,29 SEK | +5,04% | 5,94 MSEK

2025-12-18 10:00:00 Cereno Scientific anordnar kapitalmarknadsdag den 5 februari 2026 7,29 SEK | +5,04% | 5,94 MSEK

2025-12-18 10:00:00 Cereno Scientific to Host Capital Markets Day on February 5, 2026 7,29 SEK | +5,04% | 5,94 MSEK

2025-12-12 07:45:00 Cereno Scientific to Attend JPM Week and Biotech Showcase in San Francisco, US, on January 12-18, 2026 7,50 SEK | -0,99% | 4,65 MSEK

2025-12-12 07:45:00 Cereno Scientific deltar under JPM Week och vid Biotech Showcase i San Francisco, USA, den 12–18 januari 2026 7,50 SEK | -0,99% | 4,65 MSEK

2025-12-08 22:25:00 Cereno Scientific får FDA-klartecken att starta global Fas IIb-studie med CS1 vid pulmonell arteriell hypertension (PAH) 7,99 SEK | -4,20% | 15,8 MSEK

2025-12-08 22:25:00 Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH) 7,99 SEK | -4,20% | 15,8 MSEK

2025-12-03 08:00:00 Cereno Scientific presenterar nya data för CS014 vid Pharmacology 2025 den 15–18 december 8,04 SEK | +3,01% | 8,70 MSEK

2025-12-03 08:00:00 Cereno Scientific to Present New Data of CS014 at the Pharmacology 2025 on December 15-18 8,04 SEK | +3,01% | 8,70 MSEK

2025-11-30 10:17:52 Rättelse: Cereno Scientific säkrar 100 MSEK genom riktad nyemission samt lånefinansiering om 350 MSEK – når milstolpar i Q4 2027

2025-11-30 10:17:52 Correction: Cereno Scientific Secures SEK 100m in Directed Share Issue and Loan Financing of SEK 350m Reaching Milestones in Q4-2027

2025-11-28 19:31:00 Cereno Scientific: Stora aktieägare och nya investerare stödjer Bolagets långsiktiga strategi genom investering till premie

2025-11-28 19:31:00 Cereno Scientific: Major shareholders and new investors back the Company’s long-term strategy with equity investment at a premium

2025-11-28 19:30:00 Cereno Scientific Secures SEK 100m in Directed Share Issue and Loan Financing of SEK 350m Reaching Milestones in Q4-2027

2025-11-28 19:30:00 Cereno Scientific säkrar 100 MSEK genom riktad nyemission samt lånefinansiering om 350 MSEK – når milstolpar i Q4 2027

2025-11-27 07:30:00 Cereno Scientific Publishes Interim Report for Q3 2025 (July 1 – September 30, 2025) 7,28 SEK | -2,67% | 3,06 MSEK

2025-11-27 07:30:00 Cereno Scientific publicerar delårsrapport för tredje kvartalet 2025 (1 juli–30 september 2025) 7,28 SEK | -2,67% | 3,06 MSEK

2025-11-11 07:45:00 Cereno Scientific erhåller 4 miljoner kronor genom utnyttjande av 600 000 teckningsoptioner av Arena Investors, LP 6,96 SEK | -4,46% | 6,16 MSEK

2025-11-11 07:45:00 Cereno Scientific Receives SEK 4 million Through Exercise of 600,000 Warrants by Arena Investors, LP 6,96 SEK | -4,46% | 6,16 MSEK

2025-11-10 07:45:00 Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension (PAH) to the U.S. FDA 7,29 SEK | -0,55% | 2,41 MSEK

2025-11-10 07:45:00 Cereno Scientific skickar in studieprotokoll för Fas IIb-studie med CS1 vid pulmonell arteriell hypertension (PAH) till amerikanska FDA 7,29 SEK | -0,55% | 2,41 MSEK

2025-10-15 07:45:00 Cereno Scientific to Participate at BIO-Europe Fall 2025 in Vienna – the Global BioPharma Partnering Event 8,24 SEK | -2,77% | 6,91 MSEK

2025-10-15 07:45:00 Cereno Scientific deltar på BIO-Europe Fall 2025 i Wien – det globala biopharma-partneringeventet 8,24 SEK | -2,77% | 6,91 MSEK

2025-09-24 08:00:00 Cereno Scientific deltar på partnering- och investerarkonferensen Nordic Life Science Days 2025 8,72 SEK | +3,87% | 4,79 MSEK

2025-09-24 08:00:00 Cereno Scientific Participates at Partnering and Investor Conference Nordic Life Science Days 2025 8,72 SEK | +3,87% | 4,79 MSEK

2025-09-15 11:15:00 Cereno Scientific Announces Conversion of All Remaining Convertibles Following Request by Fenja Capital II A/S and Arena Investors, LP 8,87 SEK | -2,48% | 8,82 MSEK

2025-09-15 11:15:00 Cereno Scientific meddelar konvertering av alla utestående konvertibler efter påkallande av Fenja Capital II A/S och Arena Investors, LP 8,87 SEK | -2,48% | 8,82 MSEK

2025-09-03 08:00:00 Cereno Scientific Announces Sten R. Sörensen Named Finalist for ‘CEO of the Year’ at the European Lifestars Awards 2025 9,69 SEK | +0,78% | 4,57 MSEK

2025-09-03 08:00:00 Cereno Scientific meddelar att Sten R. Sörensen är finalist till ”Årets VD” vid European Lifestars Awards 2025 9,69 SEK | +0,78% | 4,57 MSEK

2025-09-02 08:00:00 Cereno Scientific deltar på GoCo Investor Day den 9 september 2025 i Göteborg 9,62 SEK | -0,88% | 7,44 MSEK

2025-09-02 08:00:00 Cereno Scientific Participates at GoCo Investor Day on September 9, 2025, in Gothenburg 9,62 SEK | -0,88% | 7,44 MSEK

2025-08-27 08:00:00 Cereno Scientific Publishes Interim Report for Q2 2025 (April 1 – June 30, 2025) 9,99 SEK | -2,06% | 12,4 MSEK

2025-08-27 08:00:00 Cereno Scientific publicerar delårsrapport för andra kvartalet 2025 (1 april–30 juni 2025) 9,99 SEK | -2,06% | 12,4 MSEK

2025-08-26 11:40:00 Cereno Scientific beviljas FDA Fast Track för CS1 vid den sällsynta sjukdomen pulmonell arteriell hypertension (PAH) 10,20 SEK | +5,59% | 23,0 MSEK

2025-08-26 11:40:00 Cereno Scientific Granted FDA Fast Track Designation for CS1 in Rare Disease Pulmonary Arterial Hypertension (PAH) 10,20 SEK | +5,59% | 23,0 MSEK

2025-08-06 18:00:00 Cereno Scientific meddelar konvertering av konvertibler efter påkallande av Fenja Capital II A/S och Arena Investors, LP 9,30 SEK | -1,59% | 7,42 MSEK

2025-08-06 18:00:00 Cereno Scientific announces conversion of convertibles following request by Fenja Capital II A/S and Arena Investors, LP 9,30 SEK | -1,59% | 7,42 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Cereno Scientific

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden